Immunotherapy-induced endocrinopathies: assessment, management and monitoring

Immunotherapy with checkpoint inhibitors has transformed the treatment of cancer, but frequently results in immune-mediated adverse events affecting multiple organs, amongst which endocrine adverse events are frequent. The patterns of endocrine adverse events differ between inhibitors of the CTLA-4...

Descripción completa

Detalles Bibliográficos
Autores principales: Nogueira, Edson, Newsom-Davis, Tom, Morganstein, Daniel L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933543/
https://www.ncbi.nlm.nih.gov/pubmed/31903179
http://dx.doi.org/10.1177/2042018819896182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933543/
https://www.ncbi.nlm.nih.gov/pubmed/31903179
http://dx.doi.org/10.1177/2042018819896182

Ejemplares similares